W.w. Grainger Earnings Calls
| Release date | Oct 31, 2025 |
| EPS estimate | $9.98 |
| EPS actual | $10.21 |
| EPS Surprise | 2.30% |
| Revenue estimate | 4.408B |
| Revenue actual | 4.657B |
| Revenue Surprise | 5.65% |
| Release date | Aug 01, 2025 |
| EPS estimate | $10.07 |
| EPS actual | $10.02 |
| EPS Surprise | -0.497% |
| Revenue estimate | 4.644B |
| Revenue actual | 4.554B |
| Revenue Surprise | -1.93% |
| Release date | May 01, 2025 |
| EPS estimate | $9.48 |
| EPS actual | $9.86 |
| EPS Surprise | 4.01% |
| Revenue estimate | 4.522B |
| Revenue actual | 4.306B |
| Revenue Surprise | -4.77% |
| Release date | Jan 31, 2025 |
| EPS estimate | $9.74 |
| EPS actual | $9.71 |
| EPS Surprise | -0.308% |
| Revenue estimate | 4.397B |
| Revenue actual | 4.233B |
| Revenue Surprise | -3.72% |
Last 4 Quarters for W.w. Grainger
Below you can see how 0IZI.L performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Jan 31, 2025 |
| Price on release | $1,051.42 |
| EPS estimate | $9.74 |
| EPS actual | $9.71 |
| EPS surprise | -0.308% |
| Date | Price |
|---|---|
| Jan 27, 2025 | $1,118.19 |
| Jan 28, 2025 | $1,131.59 |
| Jan 29, 2025 | $1,123.04 |
| Jan 30, 2025 | $1,126.16 |
| Jan 31, 2025 | $1,051.42 |
| Feb 03, 2025 | $1,041.09 |
| Feb 04, 2025 | $1,042.80 |
| Feb 05, 2025 | $1,047.21 |
| Feb 06, 2025 | $1,043.57 |
| 4 days before | -5.97% |
| 4 days after | -0.747% |
| On release day | -0.98% |
| Change in period | -6.67% |
| Release date | May 01, 2025 |
| Price on release | $1,048.33 |
| EPS estimate | $9.48 |
| EPS actual | $9.86 |
| EPS surprise | 4.01% |
| Date | Price |
|---|---|
| Apr 25, 2025 | $1,011.10 |
| Apr 28, 2025 | $1,019.37 |
| Apr 29, 2025 | $1,010.12 |
| Apr 30, 2025 | $1,015.77 |
| May 01, 2025 | $1,048.33 |
| May 02, 2025 | $1,061.42 |
| May 05, 2025 | $1,063.14 |
| May 06, 2025 | $1,044.28 |
| May 07, 2025 | $1,045.07 |
| 4 days before | 3.68% |
| 4 days after | -0.311% |
| On release day | 1.25% |
| Change in period | 3.36% |
| Release date | Aug 01, 2025 |
| Price on release | $935.57 |
| EPS estimate | $10.07 |
| EPS actual | $10.02 |
| EPS surprise | -0.497% |
| Date | Price |
|---|---|
| Jul 28, 2025 | $1,048.03 |
| Jul 29, 2025 | $1,048.55 |
| Jul 30, 2025 | $1,053.88 |
| Jul 31, 2025 | $1,040.38 |
| Aug 01, 2025 | $935.57 |
| Aug 04, 2025 | $938.70 |
| Aug 05, 2025 | $938.91 |
| Aug 06, 2025 | $949.36 |
| Aug 07, 2025 | $954.08 |
| 4 days before | -10.73% |
| 4 days after | 1.98% |
| On release day | 0.335% |
| Change in period | -8.96% |
| Release date | Oct 31, 2025 |
| Price on release | $984.68 |
| EPS estimate | $9.98 |
| EPS actual | $10.21 |
| EPS surprise | 2.30% |
| Date | Price |
|---|---|
| Oct 27, 2025 | $971.70 |
| Oct 28, 2025 | $975.56 |
| Oct 29, 2025 | $966.29 |
| Oct 30, 2025 | $963.41 |
| Oct 31, 2025 | $984.68 |
| Nov 03, 2025 | $970.66 |
| Nov 04, 2025 | $966.84 |
| Nov 05, 2025 | $961.64 |
| Nov 06, 2025 | $960.36 |
| 4 days before | 1.34% |
| 4 days after | -2.47% |
| On release day | -1.42% |
| Change in period | -1.17% |
W.w. Grainger Earnings Call Transcript Summary of Q3 2025
Grainger delivered a solid Q3 2025: reported sales were ~$4.7B (up ~5.4% daily constant currency), gross margin 38.6%, operating margin 15.2%, diluted EPS $10.21, and operating cash flow $597M with $399M returned to shareholders. Key positives: strong execution in North America and Japan, continued momentum in the Endless Assortment segment (Zoro and MonotaRO) with double-digit top-line growth and margin expansion, effective pricing/marketing actions at Zoro, and ongoing investments in technology and AI to improve customer experience and productivity. Primary near-term headwinds: LIFO-related tariff/inventory accounting impacts (timing-driven), tariff/Section 232 inflationary pressure requiring additional supplier negotiations and incremental pricing, and a government shutdown that is currently weighing on public sector sales (estimated meaningful daily impact if prolonged). Strategic action: announced agreement to sell U.K.-based Cromwell and exit the U.K., removing modest revenue (~$40M in Q4) and expected to improve consolidated operating margin (~20 bps annualized). Guidance update: narrowed full-year adjusted EPS to $39.00–$39.75 and daily organic constant currency sales growth of 4.4%–5.1%; company expects gross margins to stabilize around ~39% over time as inflation/LIFO dynamics normalize. Management reiterated confidence in long-term earnings framework: share gain in U.S., EA growth, gross margin stabilization, and SG&A growth below sales through productivity and tech investments.
Sign In
Buy 0IZI